Position in CLDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$44,652,000
+$6,588,000 QoQ
Shares Held
1,200,000
0.0% QoQ
Ownership
1.53%
of shares outstanding
% of Portfolio
0.97%
of 13F equity value
Holder Rank
#14
of 252 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bellevue Group AG holds $2,744,593,561 across 63 Biotechnology names. CLDX ranks #19 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
578,634 | $287,424,866 | |
| 2 | ARGX |
Argenx SE
|
301,000 | $279,258,770 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,048,014 | $196,272,061 | |
| 4 | ORKA |
Oruka Therapeutics, Inc.
|
1,657,190 | $157,714,772 | |
| 5 | INSM |
INSMED Inc
|
1,393,418 | $148,566,226 | |
| 6 | SRRK |
Scholar Rock Holding Corp
|
2,449,547 | $134,725,085 | |
| 7 | VRDN |
Viridian Therapeutics, Inc.\DE
|
6,731,909 | $123,665,167 | |
| 8 | RLAY |
Relay Therapeutics, Inc.
|
6,185,970 | $115,739,498 |
All Filings in CLDX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44,652,000 | 1,200,000 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $38,064,000 | 1,200,000 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $38,064,000 | 1,200,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $98,255,890 | 3,617,669 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $92,036,897 | 3,557,669 | Shares | Defined | 2025-11-14 | |
| 2025-08-18 | $88,560,537 | 3,617,669 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $67,309,029 | 3,307,569 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $55,749,812 | 3,071,615 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $77,619,711 | 3,071,615 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $104,404,193 | 3,071,615 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $109,979,471 | 2,971,615 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $117,373,931 | 2,796,615 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $95,830,299 | 2,416,296 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $52,288,000 | 1,900,000 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $61,074,000 | 1,800,000 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $64,764,000 | 1,800,000 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $80,226,000 | 1,800,000 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $50,598,000 | 1,800,000 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $24,938,000 | 925,000 | Shares | Defined | 2022-08-11 | |
| No filing history on record for this holder in this stock. | ||||||